08.05.2013 07:20 Uhr, Quelle: Wallstreet online
Actelion provides update on Phase III GRIPHON study with selexipag in pulmonary arterial hypertension - Study continues
Actelion Pharmaceuticals Ltd / Actelion provides update on Phase III GRIPHON study with selexipag in pulmonary arterial hypertension - Study continues . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the …
Weiterlesen bei Wallstreet online
JustMac.info